| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_658a4ee6a4d9bcf1d4dbbd838741c82b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2015-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da84827678881ca5e094b6015c24baab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ea5dfab05fc1bc53ee9cb2cb372c56d |
| publicationDate |
2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110452217-A |
| titleOfInvention |
Optically pure hapten for nicotine vaccine development |
| abstract |
The present invention provides chiral haptens (-)-3'-AmNic and (-)-N4N for the production of antibodies in (-)-nicotine-specific patients. The hapten can be conjugated to a suitable carrier protein and administered to a patient suffering from nicotine or tobacco addiction or habituation as a mixture of antigens, optionally including an adjuvant. |
| priorityDate |
2014-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |